NCT06928805

Brief Summary

This study aims to determine the effects of balloon inflation and pursed-lip breathing exercises, in addition to the forward-leaning position, on physiological parameters in individuals with Chronic Obstructive Pulmonary Disease (COPD). The hypotheses of the study are as follows: H1\_1: The forward-leaning position and balloon inflation breathing exercise have a positive effect on physiological parameters in patients with Chronic Obstructive Pulmonary Disease (COPD). H1\_2: The forward-leaning position and pursed-lip breathing exercise have a positive effect on physiological parameters in patients with COPD. H1\_3: There is a significant difference in physiological parameters between the balloon inflation and pursed-lip breathing exercise groups and the control group. Within this scope, the study will be conducted with three groups: Intervention Group 1: Balloon inflation exercise applied in addition to the forward-leaning position. Intervention Group 2: Pursed-lip breathing exercise applied in addition to the forward-leaning position. Control Group: Standard practice implemented in the institution where the study is conducted. Participants:

  • A home exercise program will be designed for both intervention groups, allowing them to perform the exercises independently each day.
  • The exercises will start with three sessions per day and will be increased by one session each week, continuing for a total of four weeks.
  • Participants will visit the outpatient clinic in the 4th week for assessments and tests.
  • Patients will be contacted weekly by the researcher via phone to ensure adherence to the program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2025

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
Last Updated

April 15, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

March 28, 2025

Last Update Submit

April 7, 2025

Conditions

Keywords

Chronic Obstructive Pulmonary DiseaseBreathing TechniquesForward-Leaning PositionPhysiological Parameters

Outcome Measures

Primary Outcomes (4)

  • blood pressure

    4 weeks later

  • pulse

    4 weeks later

  • respiratory rate

    4 weeks later

  • saturation

    4 weeks later

Secondary Outcomes (6)

  • Forced Vital Capacity (FVC)

    4 weeks later

  • Forced Expiratory Volume in One Second (FEV1)

    4 weeks later

  • FEV1/FVC ratio

    4 weeks later

  • Peak Expiratory Flow (PEF)

    4 weeks later

  • Modified Borg Dyspnea Scale (MBS)

    4 weeks later

  • +1 more secondary outcomes

Study Arms (3)

Pursed-lip breathing exercise

EXPERIMENTAL
Other: Pursed-lip breathing exercise

Balloon inflation exercise

EXPERIMENTAL
Other: Balloon inflation exercise

Standard treatment

EXPERIMENTAL
Other: Control (Standard treatment)

Interventions

Balloon inflation exercise was applied in addition to the forward-leaning position.

Balloon inflation exercise

The pursed-lip breathing exercise was applied in addition to the forward-leaning position.

Pursed-lip breathing exercise

Standard practice is implemented in the institution where the study is conducted.

Standard treatment

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who have no communication and cooperation problems,
  • Can speak and understand Turkish,
  • Have a baseline saturation of \>90%,
  • Have been diagnosed with Stage II and Stage III COPD,
  • Have not had any infection or COPD exacerbation for at least 3 months,
  • Have not participated in a pulmonary rehabilitation program in the last 3 months,
  • Can walk without assistance,
  • Do not have serious and/or unstable heart disease, neuromuscular disease, orthopedic disease or mental illness that may impair their physical activities of daily living,
  • Willing to participate in the study will be included.

You may not qualify if:

  • Patients who have been hospitalized since the start of the study,
  • Those receiving continuous oxygen therapy,
  • Those who have cooperation problems,
  • Those who cannot adapt to exercise,
  • Those who have 2-3 or more acute attacks per year,
  • Those with a history of pulmonary hypertension, malignancy, pulmonary thromboembolism, obstructive sleep apnea, unstable angina or myocardial infarction,
  • Patients with a pulse rate over 120/minute will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Turkey

Istanbul, Üsküdar, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Semra Aciksoz, RN, Assistant Professor, PhD

    University of Health Sciences Turkey, Hamidiye Faculty ofNursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2025

First Posted

April 15, 2025

Study Start

January 3, 2024

Primary Completion

January 4, 2025

Study Completion

February 2, 2025

Last Updated

April 15, 2025

Record last verified: 2025-03

Locations